GT Biopharma (GTBP) EBITDA Margin (QoQ) (2011 - 2015)
Powered by 
Analysis
GT Biopharma (GTBP) EBITDA Margin (QoQ) (2011 - 2015) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.37 Bn | 192.39 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.14 Bn | 176.96 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.30 Bn | 123.45 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.71 Bn | 73.72 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.30 Bn | 55.12 Bn | 1.37 Bn |
| 6 | Moderna | 53.94 Bn | 48.80 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.23 Bn | 29.92 Bn | 992.69 Mn |
| 8 | Biogen | 31.82 Bn | 30.54 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.04 Bn | 29.04 Bn | 1.16 Mn |
| 10 | GT Biopharma | 7.23 Mn | 7.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 1.87 Mn |
| Mar 31, 2013 | -5,688.00 |
| Dec 31, 2012 | 78,756.00 |
| Sep 30, 2012 | 10.19 Mn |
| Jun 30, 2012 | -6.34 Mn |
| Mar 31, 2012 | -466,667.00 |
| Dec 31, 2011 | -788,333.00 |
| Sep 30, 2011 | 2.11 Mn |
| Jun 30, 2011 | -3.88 Mn |
| Mar 31, 2011 | -449,909.00 |